FDA Inspection
Integrated Commercialization Solutions, Inc.Integrated Commercialization Solutions, Inc. – FDA Inspection, Jan 18, 2018
Record Details
This FDA Inspection record concerns Integrated Commercialization Solutions, Inc., with an inspection on January 18, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d1810abe-5715-434c-a2c9-f60bdee02a67
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1037912
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.46(b)Equipment for Environmental Control
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Integrated Commercialization Solutions, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 6, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Integrated Commercialization Solutions, Inc.
- FDA Inspection 1286868 - 2025-09-23
- FDA Inspection 637417 - 2010-01-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.